New technique improves detection of cancer DNA in blood

A team led by researchers at Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, and Harvard Medical School has developed a new method to identify thousands of DNA mutations accurately and efficiently in a patient’s blood sample with minimal sequencing. The approach, called MAESTRO, could one day enable the detection of residual cancer in patients who have undergone treatment…
Read More